Allarity Therapeutics, Inc. (ALLR) — research page
US · us-cm-kg/NASDAQ/ALLR · as of 2026-11-08
Identity and listing
The issuer is Allarity Therapeutics, Inc., listed on NASDAQ under ticker ALLR, ISIN US0167445008; its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Allarity Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | ALLR | source · 2026-11-08 |
| ISIN | US0167445008 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 49 filings across 38 filing days in the window 2025-11-08 to 2026-11-08, with a median gap of 6 days between filing days. The latest filing is dated 2026-11-02, a corporate_news filing, 6 days before the record date of 2026-11-08. On NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4,359 issuers. In sector 2834 Pharmaceutical Preparations the median filings count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's 49 filings are below the NASDAQ median and below the sector median.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 49 | 6 | 6 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 1.01,8.01,9.01) |
| 2026-10-30 | prospectus | 424B5 | 424B5 — PROSPECTUS SUPPLEMENT |
| 2026-10-30 | ad_hoc | 8-K | 8-K — CURRENT REPORT (items 1.02) |
| 2026-10-09 | directors_dealings | 4 | 4 |
| 2026-10-01 | corporate_news | 8-K | 8-K — CURRENT REPORT (items 8.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Wolf & Company P.C., located in Boston, Massachusetts. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.
Orderability
The outcome is not determinable because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record names 2 research houses on the issuer's investor-relations page: Ascendiant Capital Markets, LLC and Zacks Investment Research, Inc.
| research house | analyst | source · read date |
|---|---|---|
| Ascendiant Capital Markets, LLC | Edward Woo, CFA | issuer page · 2026-11-11 |
| Zacks Investment Research, Inc. | John D. Vandermosten, CFA | issuer page · 2026-11-11 |
Open research
The record holds 4 openly published research notes: Zacks Small-Cap Research on 2023-12-07, Ladenburg Thalmann & Co. on 2023-12-07, Ladenburg Thalmann & Co. on 2023-03-28, and Zacks Investment Research on 2022-09-13.
| date | publisher | note | kind |
|---|---|---|---|
| 2023-12-07 | Zacks Small-Cap Research | ALLR: Stenoparib Clinical Update | issuer-sponsored |
| 2023-12-07 | Ladenburg Thalmann & Co. | Estimate Changes | independent |
| 2023-03-28 | Ladenburg Thalmann & Co. | Allarity Therapeutics Inc. | independent |
| 2022-09-13 | Zacks Investment Research | Initiating Coverage | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
13 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001860657.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/ALLR (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/allr20251231_10k.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://allarity.com/analysts/ (coverage)
- 10.9
- https://allarity.com/wp-content/uploads/2023/12/Zacks_SCR_Research_12072023_ALLR_Vandermosten_Note.pdf (open research)
- 10.10
- https://allarity.com/wp-content/uploads/2023/12/ALLR-note-12.7.2023.pdf (open research)
- 10.11
- https://allarity.com/wp-content/uploads/2023/03/ALLR-note-3.28.2023-Ladenburg.pdf (open research)
- 10.12
- https://allarity.com/wp-content/uploads/2024/01/Zacks_SCR_Research_09132022_ALLR_Vandermosten.pdf (open research)
- 10.13
- https://mcp.us-cm-kg.ai/record/NASDAQ/ALLR (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US0167445008"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f4e1550ef4476432.